PaperDecline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy
References (22)
Regulation of activated protein C by protein S
- et al.
Severe homozygous protein C deficiency
J Pediat.
(1984) - et al.
Identification and quantitation of protein S in human platelets
Blood
(1985) - et al.
Human endothelial cells synthesize protein S
Blood
(1986) - et al.
Studies on coumarin anticoagulant drugs. Initiation of warfarin therapy without a loading dose
Circulation
(1968) Thrombosis
Anticoagulants, antithrombotic and thrombolytic drugs
- et al.
Human protein C: Inactivation of factor V and VIII in plasma by the activated molecule
Ann NY Acad Sci.
(1981) - et al.
Identification of an endothelial cell cofactor for thrombin catalized activation of protein C
- et al.
Deficiency of protein C in congenital thrombotic disease
J Clin Invest.
(1981)
Congenital protein C deficiency and venous thromboembolism
Cited by (84)
Hypercoagulable States
2011, Critical Care ClinicsCitation Excerpt :Acquired protein C deficiency can be caused by decreased synthesis or increased consumption. Decreased synthesis can occur in patients with liver disease or in those given warfarin.19 Warfarin decreases functional activity more than immunologic activity.
Hypercoagulable states
2010, Clinics in Chest MedicineCitation Excerpt :Acquired protein C deficiency can be caused by decreased synthesis or increased consumption. Decreased synthesis can occur in patients with liver disease or in those given warfarin.19 Warfarin decreases functional activity more than immunologic activity.
Oral anticoagulant treatment: Initiation, adjustment and use precautions
2010, Avances en DiabetologiaThe Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies
2021, Thrombosis and HaemostasisWarfarin-Induced Rapid Rise in INR Post–Cardiac Surgery Is Not Associated With Increased Bleeding Risk
2019, Annals of Pharmacotherapy
Copyright © 1987 Published by Elsevier Ireland Ltd.